NCT04837872

Brief Summary

The purpose of this study is to determine the feasibility and initial efficacy of static progressive splinting for individuals presenting with knee stiffness following total knee arthroplasty (TKA). Data from this trial will be utilized in a NIH grant application for a larger randomized controlled trial directly comparing static progressive splinting to manipulation under anesthesia (MUA) which is the current standard of care for knee stiffness after TKA.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 25, 2017

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 27, 2018

Completed
12 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 12, 2019

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

April 6, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 8, 2021

Completed
Last Updated

April 13, 2021

Status Verified

April 1, 2021

Enrollment Period

9 months

First QC Date

April 6, 2021

Last Update Submit

April 8, 2021

Conditions

Keywords

static progressive splintingmanual therapyphysical therapyrehabilitationarthrofibrosis

Outcome Measures

Primary Outcomes (1)

  • Range of Motion

    Passive knee flexion and extension measured with goniometry

    4 weeks

Secondary Outcomes (3)

  • Adherence to Splint Use

    4 weeks

  • Satisfaction with Splint

    4 weeks

  • Safety of splint use: adverse events

    4 weeks

Study Arms (1)

Multimodal Physical Therapy (MPT)

EXPERIMENTAL

The multimodal physical therapy (MPT) program consisted of manual therapy, therapeutic exercise, and utilization of a static progressive splint (Joint Active Systems SPS Knee, Effingham, IL). Although the primary focus of this study was on improving knee flexion ROM, two protocols were developed: one to improve flexion deficits and one to improve extension deficits. Participants in the MPT group received physical therapy 2x per week for 4 weeks. They were instructed to use the static progressive splint(s) 3x per day for 30 minute sessions (90 minutes total per day) for each splint (e.g., 90 minutes for flexion splint, 90 minutes for extension splint).

Other: Multimodal Physical Therapy (MPT)

Interventions

Individualized physical therapy and static progressive splint (flexion with or without extension splint).

Multimodal Physical Therapy (MPT)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Undergone a unilateral primary Total Knee Arthroplasty (TKA) for end-stage osteoarthritis
  • Knee stiffness in the first 6 weeks post-operative defined as knee flexion \< 100 degrees

You may not qualify if:

  • Preoperative knee range of motion less than 15-110 degrees
  • Intraoperative (closed) range of motion \< 0-120 degrees
  • Radiographic signs of heterotopic ossification
  • Misaligned components or component-related failures of knee prosthesis that could be responsible for difficulties with motion
  • Signs and symptoms consistent with joint infection
  • Signs and symptoms consistent with complex regional pain syndrome

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Panorama Orthopedics & Spine Center

Golden, Colorado, 80401, United States

Location

Related Publications (8)

  • Yercan HS, Sugun TS, Bussiere C, Ait Si Selmi T, Davies A, Neyret P. Stiffness after total knee arthroplasty: prevalence, management and outcomes. Knee. 2006 Mar;13(2):111-7. doi: 10.1016/j.knee.2005.10.001. Epub 2006 Feb 20.

    PMID: 16490357BACKGROUND
  • Schroer WC, Berend KR, Lombardi AV, Barnes CL, Bolognesi MP, Berend ME, Ritter MA, Nunley RM. Why are total knees failing today? Etiology of total knee revision in 2010 and 2011. J Arthroplasty. 2013 Sep;28(8 Suppl):116-9. doi: 10.1016/j.arth.2013.04.056. Epub 2013 Aug 15.

    PMID: 23954423BACKGROUND
  • Schairer WW, Vail TP, Bozic KJ. What are the rates and causes of hospital readmission after total knee arthroplasty? Clin Orthop Relat Res. 2014 Jan;472(1):181-7. doi: 10.1007/s11999-013-3030-7.

    PMID: 23645339BACKGROUND
  • Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007 Apr;89(4):780-5. doi: 10.2106/JBJS.F.00222.

    PMID: 17403800BACKGROUND
  • Bonutti PM, Marulanda GA, McGrath MS, Mont MA, Zywiel MG. Static progressive stretch improves range of motion in arthrofibrosis following total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc. 2010 Feb;18(2):194-9. doi: 10.1007/s00167-009-0947-1. Epub 2009 Oct 14.

    PMID: 19826784BACKGROUND
  • Manrique J, Gomez MM, Parvizi J. Stiffness after total knee arthroplasty. J Knee Surg. 2015 Apr;28(2):119-26. doi: 10.1055/s-0034-1396079. Epub 2014 Dec 16.

    PMID: 25513992BACKGROUND
  • Witvrouw E, Bellemans J, Victor J. Manipulation under anaesthesia versus low stretch device in poor range of motion after TKA. Knee Surg Sports Traumatol Arthrosc. 2013 Dec;21(12):2751-8. doi: 10.1007/s00167-012-2152-x. Epub 2012 Aug 3.

    PMID: 22864680BACKGROUND
  • Rauzi MR, Foran JRH, Bade MJ. Multimodal conservative management of arthrofibrosis after total knee arthroplasty compared to manipulation under anesthesia: a feasibility study with retrospective cohort comparison. Pilot Feasibility Stud. 2022 Mar 25;8(1):71. doi: 10.1186/s40814-022-01026-y.

Related Links

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 6, 2021

First Posted

April 8, 2021

Study Start

May 25, 2017

Primary Completion

February 27, 2018

Study Completion

February 12, 2019

Last Updated

April 13, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will not share

Locations